Led by former Nimbus executive Rosana Kapeller, the startup has now raised nearly $200 million in its pursuit of new autoimmune disease and cancer therapies. When Ro...

Backed by Johnson & Johnson’s venture arm, among others, Arialys plans to take medicine it acquired from Astellas Pharma into clinical testing next year. A new b...

Group aims to improve access to scientific programmes and grow ELRIG community. Cambridge, UK, 14 September 2023: The European Laboratory Research & Innovation Gr...

In a multi-year research alliance, the companies aim to combine Seagen’s antibody technology with compounds that can degrade cancer-driving proteins. Dive Brief: S...

The companies will work together to pair Shape’s adeno-associated virus technology with Otsuka’s genetic payloads. Japan’s Otsuka Pharmaceutical will work with Seatt...

The collaboration will use Verge Genomics’ platform, which has developed a novel candidate for ALS using data from human tissue. Dive Brief: Verge Genomics, a biot...

  Biotech Fluidics has expanded its family of non-invasive flowmeters for real-time monitoring of liquid flow. The range now includes four discrete devices optimized...

BIO-Europe® has grown to be recognized as Europe’s flagship partnering event. In 2022, the event made its highly anticipated return to in-person, after a two-year h...

The Food and Drug Administration’s decision last month not to approve a new treatment for one of the most common forms of depression was, in part, due to safety conce...

Dive Brief: Roche on Friday said one of its medicines succeeded in a Phase 3 trial of people whose lung tumors were driven by a well-known cancer gene, positioning...